| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 05/22/2002 | CN1349965A Fatty amido substituted desmethoxy hypocrellin with fatty ring or aromatic ring and its synthesis and application |
| 05/22/2002 | CN1085211C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/16/2002 | WO2002038191A2 Method of inactivating microorganisms in a fluid using ultraviolet radiation |
| 05/16/2002 | WO2001058434A3 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 05/16/2002 | US20020059247 Method of and apparatus for registering and reproducing homeopathic information |
| 05/16/2002 | US20020058853 Method of administering a therapeutically active substance |
| 05/16/2002 | US20020058643 Lyophilizate of lipid complex of water insoluble porphyrins |
| 05/16/2002 | US20020058057 Brachytherapy seed |
| 05/16/2002 | US20020058008 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 05/15/2002 | EP1204426A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 05/15/2002 | EP1204423A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 05/14/2002 | US6387399 Microencapsulated bioactive agents and method of making |
| 05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
| 05/10/2002 | WO2002036161A2 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | WO2001085185A3 Treatment of il-10 deficiencies |
| 05/10/2002 | WO2001051087A3 Novel treatment for eye disease |
| 05/10/2002 | WO2001034197A3 Oncolytic combinations for the treatment of cancer |
| 05/10/2002 | CA2428606A1 Novel targeted compositions for diagnostic and therapeutic use |
| 05/09/2002 | US20020055731 Methods for promoting cell transfection in vivo |
| 05/09/2002 | US20020055666 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/09/2002 | US20020054852 A carrier material reflects or absorbs or emits electromagnetic or mechanical vibration enabling the monitoring of carrier material and a drug associated with carrier, and a targeting agent bind to the site |
| 05/09/2002 | US20020054850 Monoterpenes and sesquiterpenes as chemotherapeutic sensitizers and radiation sensitizers |
| 05/08/2002 | EP1203944A1 Tumor cell identification apparatus and tumor cell identification method |
| 05/08/2002 | EP1202671A1 Microparticles useful as ultrasonic contrast agents and for lymphatic system |
| 05/08/2002 | EP1202670A1 Hollow microspheres with controlled fragility for medical use |
| 05/07/2002 | US6383481 Method for transplantation of hemopoietic stem cells |
| 05/02/2002 | WO2002034888A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 05/02/2002 | WO2002034708A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/02/2002 | WO2001062289A3 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 05/02/2002 | US20020051766 Treating an aliquot of patient's blood ex vivo with a stressor selected from temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering back into patient |
| 05/02/2002 | US20020051751 Therapy using the Mossbauer absorption phenomenon; pharmaceuticals containing radiation absorber isotope are administered and then excited; results in radiolysis of DNA resulting in lethal breaks in DNA molecules of target tissue |
| 05/02/2002 | US20020051749 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 05/02/2002 | EP1199996A1 Real-time monitoring of photodynamic therapy over an extended time |
| 05/02/2002 | CA2436515A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 05/02/2002 | CA2426741A1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 04/30/2002 | US6380228 E.g., n-(2-phenylsulfonyl-1-ethyl)-3-(4-cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/30/2002 | US6380193 Fused tricyclic compounds, methods and compositions for inhibiting PARP activity |
| 04/30/2002 | US6379648 Biodegradable glass compositions and methods for radiation therapy |
| 04/25/2002 | WO2002032415A2 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | US20020049247 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes... |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/25/2002 | US20020048586 Therapeutic compositions that alter the immune response |
| 04/25/2002 | DE10050114A1 Verwendung einer Gelmasse Using a gel mass |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/24/2002 | EP1198252A1 Radioenhanced cancer treatment using orally administered camptothecin derivatives |
| 04/24/2002 | EP0714298B1 Photosensitiser containing phthalocyanine derivative for photodynamic therapy of tumours |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/23/2002 | US6376483 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| 04/23/2002 | US6376224 Composition comprising inhibitor for membrane pumps and photoaffinity-labeled chemotherapeutic agent |
| 04/23/2002 | US6375930 Paramagnetism, photosensitivity; imaging, diagnosis, drug delivery |
| 04/23/2002 | CA2093361C Porphyrin derivative |
| 04/18/2002 | WO2002030472A2 Compositions for release of radiosensitizers, and methods of making and using the same |
| 04/18/2002 | US20020045849 Polyurethane gel mass; lithotripsy and hyperthermia apparatus for therapy |
| 04/18/2002 | US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/18/2002 | US20020045675 Use of metalNanoshells to impede the photo-oxidation of conjugated polymer |
| 04/18/2002 | US20020044909 Cyanine dye bioconjugates with bioactive molecules for diagnosis and therapy, particularly for visualization and detection of tumors |
| 04/17/2002 | EP1196143A1 Method for releasing an agent from a red blood cell |
| 04/17/2002 | EP1019037B9 Medicament containing delta-aminolevulinic acid |
| 04/17/2002 | CN1345238A Method for treatment of neurological or neuropsychiatric disorders |
| 04/16/2002 | US6373068 Apparatus and method for preparing radioactive medicines for administration |
| 04/11/2002 | WO2002028831A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | WO2001058240A3 Photodynamic therapy for treating conditions of the eye |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020041864 Method for treatment of tumors using photodynamic therapy |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/10/2002 | EP1195167A2 Use of a gel |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/09/2002 | US6368637 Method and composition for topical treatment of viral lesions |
| 04/04/2002 | WO2002026236A1 Tumor cell killing by cell cycle checkpoint abrogation combined with inhibition of the 'classical' mitogen activated protein (map) kinase pathway |
| 04/04/2002 | US20020040015 Administering to the mammal an anti-angiogenesis factor and a photosensitizer to permit to localize in the chorodial neovasculature, irradiating the chorodial neovasculature with laser light |
| 04/04/2002 | US20020039594 Solid porous matrices and methods of making and using the same |
| 04/03/2002 | EP1192450A1 High energy phototherapeutic agents |
| 04/03/2002 | EP1191949A1 Stent for neutron capture therapy and method of manufacture therefor |
| 04/03/2002 | EP1191923A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions |
| 04/03/2002 | EP1133319A4 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/03/2002 | EP0883627B1 Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 04/02/2002 | US6366801 Pharmaceutically enhanced low-energy radiosurgery |
| 04/02/2002 | US6365145 Using liposome; applying light |
| 04/02/2002 | US6364907 Method to prevent xenograft transplant rejection |
| 03/28/2002 | WO2002024273A1 Tumor treatment |
| 03/28/2002 | WO2002024226A2 Photosensitisers |
| 03/28/2002 | WO2002024199A1 Phototherapeutic and chemotherapeutic immunotherapy against tumors |
| 03/28/2002 | WO2001085202A3 Electroporation for introduction of molecules into cells |
| 03/28/2002 | WO2001074342A3 Use of locally applied dna fragments |
| 03/28/2002 | US20020038112 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 03/28/2002 | US20020037921 By adding photoactive dye(s) such as Phloxine B to an aqueous environment containing protozoa such that the resulting concentration of photoactive dye in the aqueous environment is toxic to the protozoa |
| 03/27/2002 | EP1189906A2 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| 03/27/2002 | EP1189660A2 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
| 03/27/2002 | EP1189645A2 Non-covalent bioconjugates useful for diagnosis and therapy |
| 03/27/2002 | EP1189613A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 03/27/2002 | EP0639067B1 Use of perfluorcarbons for the preparation of potentiators of the ultrasound induced hyperthermia treatment of biological tissues |
| 03/27/2002 | CN1342096A Synergistic tumorcidal response induced by histamine |
| 03/26/2002 | US6362184 Killing tumor cells |
| 03/26/2002 | US6362175 Porphyrin compounds for imaging tissue oxygen |
| 03/21/2002 | WO2002022123A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | WO2002022107A2 Pharmaceutical composition having modified carrier |
| 03/21/2002 | WO2001034196A3 Mixture containing rare earths and use thereof |
| 03/21/2002 | US20020035139 COX-2 inhibitors and the prevention of the side effects of radiation therapy |
| 03/21/2002 | US20020035093 Methods for the administration of amifostine and related compounds |